Pedro Faria Zeni
Biomedical scientist bridging bench research and biotech equity markets. PhD candidate at CEITEC with publications in Blood, JCO, and Leukemia. 5-year verified investment track record.
Three Pillars of My Work
A combination of deep biomedical research, financial analysis, and science communication that spans the gap between the lab and the market.
My goal is to advance biomedical science and help translate scientific knowledge into meaningful, real-world impact. I believe science is the most powerful tool for making better decisions, and I aim to make complex biomedical ideas more understandable, actionable, and useful for researchers, investors, and the broader community.
Scientific Authority
PhD research at CEITEC on long non-coding RNAs in B-cell malignancies. Published in Blood, Journal of Clinical Oncology, and Leukemia. Advanced training at MIT, Harvard, EMBL, UCSF, UNICAMP.
View research →Biotech Investment Insight
Thesis-driven equity research with a verified 10-year CAGR of +12.75% on eToro. Deep biotech sector analysis combining scientific due diligence with financial fundamentals.
View analysis →Science Communication
Founder of Scienarq, translating complex biomedical research into accessible content across YouTube, Instagram, and TikTok. Making science clear for investors and the public alike.
Visit Scienarq →Numbers That Tell the Story
13 years of research, 8 as a dedicated scientist, verified returns, and a proven analytical framework.
Want to Collaborate?
Whether you're a biotech firm seeking deep scientific analysis, a VC evaluating pipeline opportunities, or a media outlet needing expert commentary — I'd love to connect.
Work With Me →